US Patent Issued to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS-SACLAY, ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP), HOPITAL MARIE LANNELONGUE on April 15 for "Dizocilpine derivatives as peripheral NMDA receptor antagonists" (French Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,694, issued on April 15, was assigned to INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris), UNIVERSITE PARIS-SACLAY (Saint Aubin, France), ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (Paris) and HOPITAL MARIE LANNELONGUE (Le Plessis-Robinson, France).

"Dizocilpine derivatives as peripheral NMDA receptor antagonists" was invented by Sylvia Cohen-Kaminsky (Le Plessis-Robinson, France), Marc Humbert (Le Plessis-Robinson, France), Sebastien Dumas (Le Plessis-Robinson, France), Gilles Bru-Mercier (Le Plessis-Robinson, France), Samir Messaoudi (Chatenay-Malabry, France), Jean-Daniel Brion (Chatenay-Mal...